|
|
NPDR and Severe macular ischemia sudden vision lossvista 33 veces60 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OUEnero 11, 2026
|
|
NPDR and Severe macular ischemia sudden vision lossvista 48 veces60 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OUEnero 11, 2026
|
|
NPDR and Severe macular ischemia sudden vision lossvista 38 veces60 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OUEnero 11, 2026
|
|
NPDR and Severe macular ischemia sudden vision lossvista 41 veces60 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OUEnero 11, 2026
|
|
NPDR and Severe macular ischemia sudden vision lossvista 34 veces60 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OUEnero 11, 2026
|
|
NPDR and Severe macular ischemia sudden vision lossvista 29 veces60 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OUEnero 11, 2026
|
|
NPDR and Severe macular ischemia sudden vision lossvista 35 veces60 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OUEnero 11, 2026
|
|
NPDR and Severe macular ischemia sudden vision lossvista 36 veces60 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OUEnero 11, 2026
|
|
NPDR and Severe macular ischemia sudden vision lossvista 31 veces60 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OUEnero 11, 2026
|
|
NPDR and Severe macular ischemia sudden vision lossvista 27 veces60 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OUEnero 11, 2026
|
|
NPDR and Severe macular ischemia sudden vision lossvista 29 veces60 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OUEnero 11, 2026
|
|
NPDR and Severe macular ischemia sudden vision lossvista 33 veces60 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OUEnero 11, 2026
|
|
NPDR and Severe macular ischemia sudden vision lossvista 29 veces60 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OUEnero 11, 2026
|
|
NPDR and Severe macular ischemia sudden vision lossvista 33 veces60 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OUEnero 11, 2026
|
|
NPDR and Severe macular ischemia sudden vision lossvista 25 veces60 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OUEnero 11, 2026
|
|
NPDR and Severe macular ischemia sudden vision lossvista 27 veces60 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OUEnero 11, 2026
|
|
NPDR and Severe macular ischemia sudden vision lossvista 34 veces60 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OUEnero 11, 2026
|
|
NPDR and Severe macular ischemia sudden vision lossvista 22 veces60 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OUEnero 11, 2026
|
|
NPDR and Severe macular ischemia sudden vision lossvista 25 veces60 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OUEnero 11, 2026
|
|
NPDR and Severe macular ischemia sudden vision lossvista 21 veces60 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OUEnero 11, 2026
|
|
NPDR and Severe macular ischemia sudden vision lossvista 31 veces60 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OUEnero 11, 2026
|
|
NPDR and Severe macular ischemia sudden vision lossvista 32 veces60 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OUEnero 11, 2026
|
|
NPDR and Severe macular ischemia sudden vision lossvista 24 veces60 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OUEnero 11, 2026
|
|
NPDR and Severe macular ischemia sudden vision lossvista 30 veces60 year old female with sudden vision loss OD 1 week ago. VA 20/63, 20/200. OCT-A and FA shows severe macular ischemia OUEnero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 23 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 28 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 17 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 25 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 25 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 24 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 17 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 23 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 21 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 18 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 27 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 22 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 25 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 21 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 8 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 22 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 20 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 29 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
CRB1 Dystrophy - Inherited Retinal Disease - 14 year old malevista 21 vecesVision loss for 4 years OD 20/63, OS 20/160Enero 11, 2026
|
|
CRB1 Dystrophy - Inherited Retinal Disease - 14 year old malevista 26 vecesVision loss for 4 years OD 20/63, OS 20/160Enero 11, 2026
|
|
CRB1 Dystrophy - Inherited Retinal Disease - 14 year old malevista 27 vecesVision loss for 4 years OD 20/63, OS 20/160Enero 11, 2026
|
|
CRB1 Dystrophy - Inherited Retinal Disease - 14 year old malevista 16 vecesVision loss for 4 years OD 20/63, OS 20/160Enero 11, 2026
|
|
CRB1 Dystrophy - Inherited Retinal Disease - 14 year old malevista 22 vecesVision loss for 4 years OD 20/63, OS 20/160Enero 11, 2026
|
|
CRB1 Dystrophy - Inherited Retinal Disease - 14 year old malevista 22 vecesVision loss for 4 years OD 20/63, OS 20/160Enero 11, 2026
|
|
CRB1 Dystrophy - Inherited Retinal Disease - 14 year old malevista 31 vecesVision loss for 4 years OD 20/63, OS 20/160Enero 11, 2026
|
|
Bullous Retinoschisis - Asymptomaticvista 36 vecesDiciembre 17, 2025
|
|
Bullous Retinoschisis - Asymptomaticvista 32 vecesDiciembre 17, 2025
|
|
Bullous Retinoschisis - Asymptomaticvista 36 vecesDiciembre 17, 2025
|
|
Hemi-CRVO - dual trunk veinvista 30 veces81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomyDiciembre 17, 2025
|
|
Hemi-CRVO - dual trunk veinvista 22 veces81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomyDiciembre 17, 2025
|
|
Hemi-CRVO - dual trunk veinvista 27 veces81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomyDiciembre 17, 2025
|
|
Hemi-CRVO - dual trunk veinvista 30 veces81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomyDiciembre 17, 2025
|
|
Hemi-CRVO - dual trunk veinvista 24 veces81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomyDiciembre 17, 2025
|
|
Hemi-CRVO - dual trunk veinvista 22 veces81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomyDiciembre 17, 2025
|
|
Hemi-CRVO - dual trunk veinvista 20 veces81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomyDiciembre 17, 2025
|
|
Hemi-CRVO - dual trunk veinvista 22 veces81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomyDiciembre 17, 2025
|
|
Hemi-CRVO - dual trunk veinvista 20 veces81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomyDiciembre 17, 2025
|
|
Hemi-CRVO - dual trunk veinvista 20 veces81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomyDiciembre 17, 2025
|
|
Hemi-CRVO - dual trunk veinvista 16 veces81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomyDiciembre 17, 2025
|
|
Hemi-CRVO - dual trunk veinvista 14 veces81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomyDiciembre 17, 2025
|
|
Hemi-CRVO - dual trunk veinvista 16 veces81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomyDiciembre 17, 2025
|
|
Hemi-CRVO - dual trunk veinvista 21 veces81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomyDiciembre 17, 2025
|
|
Hemi-CRVO - dual trunk veinvista 22 veces81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomyDiciembre 17, 2025
|
|
Hemi-CRVO - dual trunk veinvista 15 veces81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomyDiciembre 17, 2025
|
|
Hemi-CRVO - dual trunk veinvista 28 veces81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomyDiciembre 17, 2025
|
|
Hemi-CRVO - dual trunk veinvista 19 veces81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomyDiciembre 17, 2025
|
|
Hemi-CRVO - dual trunk veinvista 19 veces81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomyDiciembre 17, 2025
|
|
Hemi-CRVO - dual trunk veinvista 21 veces81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomyDiciembre 17, 2025
|
|
Hemi-CRVO - dual trunk veinvista 16 veces81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomyDiciembre 17, 2025
|
|
Hemi-CRVO - dual trunk veinvista 15 veces81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomyDiciembre 17, 2025
|
|
Hemi-CRVO - dual trunk veinvista 19 veces81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomyDiciembre 17, 2025
|
|
Perivascular Exudative Vascular Complex - Perifoveal Microaneurysmvista 22 veces59 year old man - asymptomatic - not diabeticDiciembre 17, 2025
|
|
Perivascular Exudative Vascular Complex - Perifoveal Microaneurysmvista 27 veces59 year old man - asymptomatic - not diabeticDiciembre 17, 2025
|
|
Perivascular Exudative Vascular Complex - Perifoveal Microaneurysmvista 20 veces59 year old man - asymptomatic - not diabeticDiciembre 17, 2025
|
|
Perivascular Exudative Vascular Complex - Perifoveal Microaneurysmvista 17 veces59 year old man - asymptomatic - not diabeticDiciembre 17, 2025
|
|
Perivascular Exudative Vascular Complex - Perifoveal Microaneurysmvista 17 veces59 year old man - asymptomatic - not diabeticDiciembre 17, 2025
|
|
Perivascular Exudative Vascular Complex - Perifoveal Microaneurysmvista 29 veces59 year old man - asymptomatic - not diabeticDiciembre 17, 2025
|
|
Perivascular Exudative Vascular Complex - Perifoveal Microaneurysmvista 17 veces59 year old man - asymptomatic - not diabeticDiciembre 17, 2025
|
|
Perivascular Exudative Vascular Complex - Perifoveal Microaneurysmvista 18 veces59 year old man - asymptomatic - not diabeticDiciembre 17, 2025
|
|
Perivascular Exudative Vascular Complex - Perifoveal Microaneurysmvista 31 veces59 year old man - asymptomatic - not diabeticDiciembre 17, 2025
|
|
Perivascular Exudative Vascular Complex - Perifoveal Microaneurysmvista 27 veces59 year old man - asymptomatic - not diabeticDiciembre 17, 2025
|
|
Perivascular Exudative Vascular Complex - Perifoveal Microaneurysmvista 28 veces59 year old man - asymptomatic - not diabeticDiciembre 17, 2025
|
|
Perivascular Exudative Vascular Complex - Perifoveal Microaneurysmvista 35 veces59 year old man - asymptomatic - not diabeticDiciembre 17, 2025
|
|
Severe NPDR with non-perfusion on FAvista 34 veces64 year old man with 20/32 vision in both eyes and mild blurring. FA shows non-perfusion but no proliferationNoviembre 23, 2025
|
|
Severe NPDR with non-perfusion on FAvista 41 veces64 year old man with 20/32 vision in both eyes and mild blurring. FA shows non-perfusion but no proliferationNoviembre 23, 2025
|
|
Severe NPDR with non-perfusion on FAvista 30 veces64 year old man with 20/32 vision in both eyes and mild blurring. FA shows non-perfusion but no proliferationNoviembre 23, 2025
|
|
Severe NPDR with non-perfusion on FAvista 35 veces64 year old man with 20/32 vision in both eyes and mild blurring. FA shows non-perfusion but no proliferationNoviembre 23, 2025
|
|
Severe NPDR with non-perfusion on FAvista 45 veces64 year old man with 20/32 vision in both eyes and mild blurring. FA shows non-perfusion but no proliferationNoviembre 23, 2025
|
|
Severe NPDR with non-perfusion on FAvista 25 veces64 year old man with 20/32 vision in both eyes and mild blurring. FA shows non-perfusion but no proliferationNoviembre 23, 2025
|
|
Severe NPDR with non-perfusion on FAvista 44 veces64 year old man with 20/32 vision in both eyes and mild blurring. FA shows non-perfusion but no proliferationNoviembre 23, 2025
|
|
Severe NPDR with non-perfusion on FAvista 45 veces64 year old man with 20/32 vision in both eyes and mild blurring. FA shows non-perfusion but no proliferationNoviembre 23, 2025
|
|
Severe NPDR with non-perfusion on FAvista 44 veces64 year old man with 20/32 vision in both eyes and mild blurring. FA shows non-perfusion but no proliferationNoviembre 23, 2025
|
|
Severe NPDR with non-perfusion on FAvista 23 veces64 year old man with 20/32 vision in both eyes and mild blurring. FA shows non-perfusion but no proliferationNoviembre 23, 2025
|
|
Severe NPDR with non-perfusion on FAvista 29 veces64 year old man with 20/32 vision in both eyes and mild blurring. FA shows non-perfusion but no proliferationNoviembre 23, 2025
|
|
Severe NPDR with non-perfusion on FAvista 16 veces64 year old man with 20/32 vision in both eyes and mild blurring. FA shows non-perfusion but no proliferationNoviembre 23, 2025
|
|
Severe NPDR with non-perfusion on FAvista 14 veces64 year old man with 20/32 vision in both eyes and mild blurring. FA shows non-perfusion but no proliferationNoviembre 23, 2025
|
|
| 17726 archivos en 178 página(s) |
1 |
 |
|
|
|
|
|
|
|
|
|
